Antiproliferative effects of allium derivatives from garlic

J T Pinto1, R S Rivlin

  • 1Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. pintoj@mskcc.org

Insights

Garlic compounds, known as allium derivatives, show promise in fighting human cancers by inhibiting cell growth. These compounds affect cell cycles and immune responses, warranting further study for cancer prevention.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Allium derivatives from garlic exhibit significant antiproliferative effects on various human cancer cell lines.
  • These compounds influence both hormone-responsive and hormone-unresponsive cancer cells.
  • Evidence suggests a role for allium derivatives in regulating immune function and inflammation.

Purpose of the Study:

  • To summarize the antiproliferative actions of allium derivatives on human cancers.
  • To highlight the mechanisms by which these compounds inhibit cancer cell growth, including apoptosis and cell cycle regulation.
  • To underscore the need for further research into the application of allium derivatives for cancer prevention and control.

Main Methods:

  • Review of existing evidence on allium derivatives and cancer.
  • In vitro studies on human prostate cancer (LNCaP) and breast cancer (MCF-7) cell lines.
  • Analysis of cellular pathways including apoptosis, cell cycle progression, and signal transduction.

Main Results:

  • Allium derivatives induce apoptosis and regulate cell cycle progression in cancer cells.
  • These compounds modify signal transduction pathways and nuclear factors involved in proliferation.
  • Demonstrated inhibition of proliferation in LNCaP and MCF-7 human cancer cell lines.

Conclusions:

  • Allium derivatives possess significant antiproliferative properties against human cancers.
  • Further investigation is needed to elucidate the precise mechanisms of action.
  • Potential therapeutic applications for cancer prevention and control exist for allium derivatives.